Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)

clinical trial
MedicalStudy clinical_trial Q61957452
Press Enter · cited answer in seconds

Summary

Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) is a clinical trial[1].

Key Facts

  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) is in the country of Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) — country (P17): United States[2].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s instance of is recorded as Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) — instance of (P31): clinical trial[3].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s start time is recorded as +2012-02-29T00:00:00Z[4].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s end time is recorded as +2016-07-31T00:00:00Z[5].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s main subject is recorded as Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) — main subject (P921): urinary incontinence[6].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s number of participants is recorded as {'unit': '1', 'amount': '+386'}[7].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s title is recorded as Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)[8].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s short name is recorded as ROSETTA[9].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+21'}[10].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s ClinicalTrials.gov ID is recorded as NCT01502956[11].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s research intervention is recorded as Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) — research intervention (P4844): botulinum toxin type A[12].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s clinical trial phase is recorded as Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) — clinical trial phase (P6099): phase III clinical trial[13].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s research site is recorded as Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) — research site (P6153): UNM Los Lunas[14].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s research site is recorded as Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) — research site (P6153): University of Pennsylvania[15].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s research subject recruitment status is recorded as Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) — research subject recruitment status (P8005): completed[16].
  • Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)'s study type is recorded as Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) — study type (P8363): interventional study[17].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA). Retrieved May 3, 2026, from https://4ort.xyz/entity/refractory-overactive-bladder-sacral-neuromodulation-v-botulinum-toxin-assessment-rosetta-
MLA “Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA).” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/refractory-overactive-bladder-sacral-neuromodulation-v-botulinum-toxin-assessment-rosetta-.
BibTeX @misc{4ortxyz_refractory-overactive-bladder-sacral-neuromodulation-v-botulinum-toxin-assessment-rosetta-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)}}, year = {2026}, url = {https://4ort.xyz/entity/refractory-overactive-bladder-sacral-neuromodulation-v-botulinum-toxin-assessment-rosetta-}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) — https://4ort.xyz/entity/refractory-overactive-bladder-sacral-neuromodulation-v-botulinum-toxin-assessment-rosetta- (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/refractory-overactive-bladder-sacral-neuromodulation-v-botulinum-toxin-assessment-rosetta- · Last refreshed: